Tokyo, Feb. 28 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060769) titled 'Post Marketing Survey of Healthcare Professionals Using a Viscosity Adjustable High Calorie Formula' on Feb. 27.
Study Type:
Observational
Primary Sponsor:
Institute - Nestle Health Science Company, Nestle Japan Ltd.
Condition:
Condition - Gastroesophageal reflux
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - This study aims to assess the usefulness of a viscosity adjustable high calorie liquid formula through a questionnaire survey of healthcare professionals who have used it in patient care.
Basic objectives2 - Safety,Efficacy
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - 1. Healthcare professionals who provided voluntary consent via the study website.
2. Healthcare professionals who have used a viscosity adjustable high calorie liquid formula in patients with gastroesophageal reflux symptoms.
3. Healthcare professionals who have obtained permission from the head of their medical institution to respond to the questionnaire.
3. Healthcare professionals who can independently complete the questionnaire.
Key exclusion criteria - None
Target Size - 200
Recruitment Status:
Recruitment status - Enrolling by invitation
Date of protocol fixation - 2026 Year 02 Month 24 Day
Date of IRB - 2026 Year 02 Month 26 Day
Anticipated trial start date - 2026 Year 02 Month 27 Day
Last follow-up date - 2026 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069379
Disclaimer: Curated by HT Syndication.
